Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1990 1
1991 1
1992 1
1993 1
1994 4
1995 2
1996 2
1997 6
1998 3
1999 7
2000 8
2001 5
2002 5
2003 10
2004 10
2005 18
2006 14
2007 12
2008 24
2009 21
2010 21
2011 15
2012 16
2013 13
2014 9
2015 11
2016 12
2017 7
2018 8
2019 11
2020 6
2021 8
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

267 results
Results by year
Filters applied: . Clear all
Page 1
Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment.
van de Wall S, Santegoets KCM, van Houtum EJH, Büll C, Adema GJ. van de Wall S, et al. Among authors: adema gj. Trends Immunol. 2020 Apr;41(4):274-285. doi: 10.1016/j.it.2020.02.001. Epub 2020 Mar 2. Trends Immunol. 2020. PMID: 32139317 Review.
Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates.
Cassetta L, Baekkevold ES, Brandau S, Bujko A, Cassatella MA, Dorhoi A, Krieg C, Lin A, Loré K, Marini O, Pollard JW, Roussel M, Scapini P, Umansky V, Adema GJ. Cassetta L, et al. Among authors: adema gj. Cancer Immunol Immunother. 2019 Apr;68(4):687-697. doi: 10.1007/s00262-019-02302-2. Epub 2019 Jan 25. Cancer Immunol Immunother. 2019. PMID: 30684003 Free PMC article. Review.
Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity.
Büll C, Boltje TJ, Balneger N, Weischer SM, Wassink M, van Gemst JJ, Bloemendal VR, Boon L, van der Vlag J, Heise T, den Brok MH, Adema GJ. Büll C, et al. Among authors: adema gj. Cancer Res. 2018 Jul 1;78(13):3574-3588. doi: 10.1158/0008-5472.CAN-17-3376. Epub 2018 Apr 27. Cancer Res. 2018. PMID: 29703719 Free article.
Interactions among myeloid regulatory cells in cancer.
Umansky V, Adema GJ, Baran J, Brandau S, Van Ginderachter JA, Hu X, Jablonska J, Mojsilovic S, Papadaki HA, Pico de Coaña Y, Santegoets KCM, Santibanez JF, Serre K, Si Y, Sieminska I, Velegraki M, Fridlender ZG. Umansky V, et al. Among authors: adema gj. Cancer Immunol Immunother. 2019 Apr;68(4):645-660. doi: 10.1007/s00262-018-2200-6. Epub 2018 Jul 12. Cancer Immunol Immunother. 2019. PMID: 30003321 Review.
Merkel Cell Carcinoma: New Trends.
Zwijnenburg EM, Lubeek SFK, Werner JEM, Amir AL, Weijs WLJ, Takes RP, Pegge SAH, van Herpen CML, Adema GJ, Kaanders JHAM. Zwijnenburg EM, et al. Among authors: adema gj. Cancers (Basel). 2021 Mar 31;13(7):1614. doi: 10.3390/cancers13071614. Cancers (Basel). 2021. PMID: 33807446 Free PMC article. Review.
Siglec Signaling in the Tumor Microenvironment.
van Houtum EJH, Büll C, Cornelissen LAM, Adema GJ. van Houtum EJH, et al. Among authors: adema gj. Front Immunol. 2021 Dec 13;12:790317. doi: 10.3389/fimmu.2021.790317. eCollection 2021. Front Immunol. 2021. PMID: 34966391 Free PMC article. Review.
Lipid Droplets as Immune Modulators in Myeloid Cells.
den Brok MH, Raaijmakers TK, Collado-Camps E, Adema GJ. den Brok MH, et al. Among authors: adema gj. Trends Immunol. 2018 May;39(5):380-392. doi: 10.1016/j.it.2018.01.012. Epub 2018 Feb 22. Trends Immunol. 2018. PMID: 29478771 Review.
Immunocombination therapy for high-risk neuroblastoma.
Kroesen M, Lindau D, Hoogerbrugge P, Adema GJ. Kroesen M, et al. Among authors: adema gj. Immunotherapy. 2012 Feb;4(2):163-74. doi: 10.2217/imt.11.169. Immunotherapy. 2012. PMID: 22394368 Review.
Sialic acids sweeten a tumor's life.
Büll C, Stoel MA, den Brok MH, Adema GJ. Büll C, et al. Among authors: adema gj. Cancer Res. 2014 Jun 15;74(12):3199-204. doi: 10.1158/0008-5472.CAN-14-0728. Epub 2014 May 15. Cancer Res. 2014. PMID: 24830719 Free article. Review.
267 results